Organic Expansion To Bring A Major Breakthrough In The Proteomics MarketPosted by Merin John on June 24th, 2021 Over the years, the proteomics market has created new opportunities in life science industries due to increasing usage of the technology in cancer drug development and personalized medicine. As per findings of Persistence Market Research (PMR), the global market for proteomics will witness stupendous expansion at a CAGR of 17% over the forecast period (2019-2029). With growth projected to showcase over 5X expansion in revenues, the global proteomics market remains buoyed by advancements in high-throughput technologies that are constantly being used to investigate proteomes. As proteomics are widely used in diagnostics, prognostics, and various other healthcare applications, there has been increasing demand for proteomic techniques in disease diagnostics and drug development. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/31378 Companies covered in Proteomics Market Report
Key Takeaways of Proteomics Market Study
“Technological advancements in proteomic techniques and growing demand for proteomics research for drug development focusing on large-scale manufacturing of personalized medicine are bringing in new avenues for market development,” says a PMR analyst. Potential Impact of COVID-19 on the Proteomics Market The global outbreak of COVID-19 is indirectly affecting the proteomics market, as applications in pharmaceutical companies witness a downtrend. This is mainly due to hampered drug production and the preference of pharmaceutical companies toward the production of vital drugs that are needed now. On the other hand, the proteomics market will gain traction, as numerous proteomic labs across the U.S. and Europe are taking up the research of therapeutic methods for fighting the coronavirus, thus providing insights about the inclusion of proteomics in the vaccine for COVID-19. This factor is expected to partially subdue the shortcomings that the market will face in the foreseeable future, due to the pandemic. Acquisitions and Partnerships – Key Strategies of Market Players Key players in the proteomics market are focused on improving their product portfolios though the launch of new products. For instance, in June 2019, Thermo Fisher Scientific, Inc launched New-Generation Benchtop Mass Spectrometer Advances Quantitative Proteomics and Translational Research. Manufacturers are also working toward getting new products approved by regulatory bodies and launching them at the earliest. Various players in the proteomics market are focusing on growth strategies such as acquisitions and partnerships. For example, in June 2019, Thermo Fisher Scientific, Inc announced a collaboration with Biognosys for Advance Plasma Quantitation Methods in Proteomics. What Does the Report Cover? Persistence Market Research offers a unique perspective and actionable insights on the proteomics market in its latest study, presenting historical demand assessment of 2014–2018 and projections for 2019–2029, on the basis of component (instruments, reagents and kits, core proteomics services, bioinformatics services, and quantitation services), technology (microarrays, X-Ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis, and surface plasma resonance systems), application (drug discovery, clinical diagnosis, and cancer research), and end user (contract research organizations (CROs), research & academic institutions, and pharma & biotech companies), across seven key regions. Like it? Share it! More by this author |